Maria Teresa Abreu (University of Miami, USA) discussed some new strategies to design clinical trials.
Theresa Pizarro, (Case Western Reserve University School of Medicine) discussed the roles of epithelial barrier’s cytokines, gut microbiome and Gasdermin in IBD patients.
The results of a new research done in mice suggest that gut bacteria can regulate host physiology by metabolizing vitamin A.
Probiotic supplements with ethanol-metabolizing activity may help reduce the disease burden of excessive alcohol consumption.
Sudarshen Paramsothy (University of New South Wales, Australia) discussed the controversials about FMT in IBD patients.
New research in mice suggests that two MACs, L-arabinose and sucrose, have specific effects on gut microbes that may prevent diet-induced obesity.
Herbert Tilg (University Innsbruck, Austria) discussed the relationship between Inflammatory Bowel Diseases and gut microbiome.
The findings of a new research show that gut bacteria can become harmful over time by gaining the ability to escape the intestine and persist in other organs where they…
The findings of a new research suggest that changes in the microbial composition of people with COVID-19 could be used as a biomarker of invasion of lung pathogens and dysbiosis…
Together with Prof. Ted Dinan (UCC Ireland), in this episode we discuss the link between gut and depression.
